Expanding Horizons in Cancer Therapeutics Targeting the Complement Pathway
Time: 11:30 am
day: Day Two
- Unravelling novel intricacies of complement cancer nexus will offer key insights
- Are mechanistic models authentic predictors of clinical scenario?
- Discussing why the selection of the right patient subsets for complement inhibition is the path forward